Page last updated: 2024-08-23

escitalopram and Benign Neoplasms

escitalopram has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alexandre, M; Economos, G; Glehen, O; Haesebaert, J; Perceau-Chambard, E; Subtil, F; Villeneuve, L	1

Trials

1 trial(s) available for escitalopram and Benign Neoplasms

Article	Year
What is the effectiveness and safety of mirtazapine versus escitalopram in alleviating cancer-associated poly-symptomatology (the MIR-P study)? A mixed-method randomized controlled trial protocol. BMC palliative care, 2022, May-23, Volume: 21, Issue:1 Topics: Antidepressive Agents; Depressive Disorder, Major; Escitalopram; Humans; Mirtazapine; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome	2022

Article

Year

What is the effectiveness and safety of mirtazapine versus escitalopram in alleviating cancer-associated poly-symptomatology (the MIR-P study)? A mixed-method randomized controlled trial protocol.

BMC palliative care, 2022, May-23, Volume: 21, Issue:1

Topics: Antidepressive Agents; Depressive Disorder, Major; Escitalopram; Humans; Mirtazapine; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome

2022